CanSino Biologics Inc. (HKG:6185)

CanSino Biologics Revenue

CanSino Biologics had revenue of 190.28M CNY in the quarter ending March 31, 2026, with 38.73% growth. This brings the company's revenue in the last twelve months to 1.12B, up 28.97% year-over-year. In the year 2025, CanSino Biologics had annual revenue of 1.07B with 26.18% growth.

• Revenue (ttm): 1.12B CNY
• Revenue Growth: +28.97%
• P/S Ratio: 7.53
• Revenue / Employee: 988.56K CNY
• Employees: 1,134
• Market Cap: 9.60B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.07B	221.57M	26.18%
Dec 31, 2024	846.34M	489.25M	137.01%
Dec 31, 2023	357.08M	-677.51M	-65.49%
Dec 31, 2022	1.03B	-3.27B	-75.94%
Dec 31, 2021	4.30B	4.27B	17,174.82%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 19, 2026

Data Sources Report a data error